Postoperative Pain
To manage moderate to severe pain after surgery.
Tramadol
ULTOR is a premium formulation of Tramadol, available in ready-to-use OPC (One-Point-Cut) ampoules designed for fast and safe administration for pain management. Each ampoule delivers Tramadol for effective analgesic action in acute situations.
ULTOR is indicated for the management of pain in adults that requires an opioid analgesic when alternative treatments are not adequate. It is suitable for intramuscular (I.M.) and intravenous (IV) use in the following conditions:
To manage moderate to severe pain after surgery.
Pain relief in cases of sports injuries, accidents or acute medical conditions.
Management of moderate to severe chronic pain when clinically indicated.
For fluctuating pain associated with cancer that requires flexible dosing.
Other cases of moderate to severe pain requiring opioid analgesia, according to medical evaluation.
Tramadol is a centrally acting synthetic opioid analgesic.
It exerts its effect through mu-opioid receptor agonism and inhibition of norepinephrine and serotonin reuptake.
Rapid onset of action, providing fast pain relief.
How Ultor works
Ultor®Tramadol HClULTOR is a premium formulation of Tramadol, available in ready-to-use OPC (One-Point-Cut) ampoules designed for fast and safe administration for pain management. Each ampoule delivers Tramadol for effective analgesic action in acute situations.
ULTOR is indicated for the management of pain in adults that requires an opioid analgesic when alternative treatments are not adequate. It is suitable for intramuscular (I.M.) and intravenous (IV) use in postoperative pain, acute injury, chronic pain, cancer-related pain, and other moderate to severe pain requiring opioid analgesia, according to medical evaluation.
Tramadol is a centrally acting synthetic opioid analgesic. It exerts its effect through mu-opioid receptor agonism and inhibition of norepinephrine and serotonin reuptake, with rapid onset of action providing fast pain relief.
The dose should be adjusted according to pain severity and the patient’s response. Typical starting dose: 50–100 mg every 4–6 hours as needed. Do not exceed 400 mg/day. For IV administration, dilute in sterile solution and administer slowly over 2–3 minutes. For IM administration, inject directly into the muscle tissue.
Reduced particle emission upon opening. Enamel flakes from the ceramic rings can no longer fall into the medication. Cleaner break appearance, reduced risk of sharp glass spikes when opening, reducing the risk of injury. Significant reduction in the risk of ampoules that are very difficult to open.
Use only when the benefits outweigh the risks. Verify that non-opioid treatments are insufficient before prescribing. Initiate and adjust treatment under medical supervision, considering the patient’s response and tolerance.
Monitor patients for respiratory depression, especially within the first 24–72 hours of starting therapy and following dose increases. Use with caution in patients with severe hepatic or renal impairment. Contraindicated in patients with known hypersensitivity to tramadol or opioids.
Each 2 ml ampoule contains tramadol hydrochloride 100 mg. Ultor is presented in a box of 10 and 100 ampoules, following the British Pharmacopoeia standard.
Manufactured according to the strict specifications of the British Pharmacopoeia to ensure consistency and superior quality. Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.
Manufactured according to the strict specifications of the British Pharmacopoeia to ensure consistency and superior quality.
Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.